|
George Dunbar joined Aastrom as Chief Executive Officer President and a member of the Company's Board of Directors in July 2006. Over the last 15 years Mr. Dunbar served as Chief Executive Officer and Director of Quantum Dot Corporation Targesome Inc. and Epic Therapeutics, as Acting President and Chief Executive Officer of StemCells Inc. (formerly CytoTherapeutics); and as President and Chief Executive Officer of Metra Biosystems Inc. Prior to that time Mr. Dunbar held senior positions in licensing business development and marketing with The Ares-Serono Group and Amersham International. In addition to serving as a board member of companies where he also led the executive management team Mr. Dunbar has other significant board experience serving both public and private companies. He currently serves on the board of Accuri Cytometers and Sonus Pharmaceuticals as well as the MBA Advisory Board of the College of Business at Auburn University. Mr. Dunbar received a B.S. in Electrical Engineering and an MBA from Auburn University. | 